PhRMA sues Trump admin; biotech tariffs stoke industry frustration

PhRMA has filed a lawsuit against the Trump administration, though the specific legal claims are not detailed in this summary. Concurrently, smaller biotech firms are expressing frustration over tariffs, indicating trade policy is pressuring the sector. The lawsuit signals an escalation in pharma-industry opposition to administration policy, while tariff concerns add cost and supply-chain uncertainty for biotech.